CADL:NASDAQ, Candel Therapeutics, Inc.

CADL stock overview

Candel Therapeutics, Inc. (CADL:NASDAQ) closed at $5.04 on November 20, 2026, down 1.75% on the day. The stock trades 64.0% below its 52-week high of $14.00 and 15.9% above its 52-week low of $4.35. Over the past year, it gained 11.3%. Candel Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$5.04
Day change
-1.75%
Volume
1,722,327
Average volume
1,258,337
Market cap
395M+
52-week range
$4.35 – $14.00
50-day average
$9.21
200-day average
$8.40

Price action over the past year

In 252 trading sessions since November 20, 2025, CADL closed higher on 121 days (48%). Its best day was April 17, 2026 (+23.45%) and its worst was November 13, 2026 (-26.10%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

CADL news

About Candel Therapeutics, Inc.

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Similar stocks

Find more stocks like CADL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.